insights_auto
Why is CHGCY up 3,90%?
Dive Deeperchevron_right
CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
19,99 $
arrow_upward
+3,90%(+0,75) 1D
15 հոկ, 14:48:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHGCY...
Open
20,62 $
High
20,62 $
Low
19,08 $
Mkt. cap
10,52 տրլն
Avg. vol.
324,20 հզր
Volume
402,30 հզր
52-wk high
34,84 $
52-wk low
18,33 $
Beta
0,56
Shares outstanding
3,36 մլրդ
No. of employees
5 հզր
Open
20,62 $
High
20,62 $
Low
19,08 $
Mkt. cap
10,52 տրլն
Avg. vol.
324,20 հզր
Volume
402,30 հզր
52-wk high
34,84 $
52-wk low
18,33 $
Beta
0,56
Shares outstanding
3,36 մլրդ
No. of employees
5 հզր
News stories
From web sources and news partners
ad-hoc-news.de
·
10 ժամ առաջ
Chugai reports vamikibart data. Chugai Pharmaceutical stock costs EUR 35.28
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical ADR